SOME IMMUNOMODULATING EFFECTS OF ATORVASTATIN
Abstract
The present study was conducted to investigate the immune-pharmacological effects of atorvastatin on the cellular and humoral immune response of rabbits (either non-vaccinated or vaccinated with rabbit hemorrhagic viral disease vaccine). Two blood samples were collected from each rabbit (5rabbits /group) at the 1st and 3rd day, 1st, 2nd and 3rd week post vaccination and/or drug administration for studying both cellular and humoral immune response.
Keywords:
Cancer, Tumors, Pain, Nausea and Vomiting, Atorvastatin, Cellular and Humeral ImmunityReferences
Adams, S.P., Tsang, M. and Wright, J.M. (2015): Lipid lowering efficacy of Atorvastatin. Cochrane Database of Systemic Reviews 12(3): 1-462 CD008226.
Bianchi, S., Bigazzi, R. and Compese, V.M. (2003): A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney diseases. American Journal of Kidney Diseases. Vol. 41 (3): 565-570.
Cunningham, S.M., Rush, J.E. and Freeman, L.M. (2013): Short-term effects of Atorvastatin in normal dogs and dogs with congestive heart failure due to myxomatous mitral valve disease. J Vet Intern Med; 27: 985-989.
Danseh, F.R., Anel, R.L., Zeng, L., Lomasney, J., Sahai, A. and Kanwar, Y.S. (2003): Immunomodulatory effects of HMG-CoA reductase inhibitors. Archivum Immunologiae et Therapeutic Experimentalis, 51, 139-148.
Davis, B.J. (1964): Disc electrophoresis, methods and application to human serum proteins. J. Ann. New York Acad. Sci. 121: 404-428.
Dumas, B.T., Watson, W.A. and Biggs, H.G. (1971): Quantitative colorimetric determination of albumin in serum or plasma. Clin. Chem. Act. 31: 87.
El-Sayed, M.G. and Manal, B.M. (2007): The immunomodulatory effects amoxicillin and florfenicol in buffalo after vaccination with FMD vaccine. 5th Int. Sci. Conf., Mansoura, April, 69: 801-817.
Endo, A.A. (2010): Historical perspective on the discovery of statins. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 86: 484–493.
Flora, F. (2014): Treated patients biochemical studies on hepatotoxicity of atorvastatin. International Journal of Biochemistry and Biophysics. 2 (4): 41-62.
Gornal, A.G., Bardawil, C. J. and David, M.M. (1949): Determination of serum protein b means of the biuret reaction. J. Bio. Chem. 177: 751-766.
Holowetz, L.A. and Kenney, W.L. (2011): Oral atorvastatin therapy increase nitric oxide dependant cutaneaous vasodilation in humans by decreasing ascorbate sensitive oxidants. Am. J. Physiol. Regul. Integr. Comp. Physiol. Sep; 301 (3): R763-8.
Kim, P.K., Zamora, R., Petrosko, P. and Billiard, T.R. (2001): The regulatory role of nitric oxide in apoptosis. Int. Immunopharmacol. 1: 1421-1441.
Mose, F.H., Larsen, T., Bech, J.N. and Pedersen, E.B. (2013): Effects of atorvastatin on systemic and renal nitric oxide in healthy man. Journal Clinical and Experimental Hypertension. 35(2): 148-157.
Nathan, C. (1992): Nitric oxide as a secondary product of mammalian cells. FASEBJ. 6: 3051-3064.
Oliveira, A.G., Carvalho, B.M., Tobar, N., Ropelle, E.R., Pauli, J.R., Bagarolli, R.A., Guadagnini, D., Carvalheir, J.B. and Saad, M.J. (2011): Atorvastatin improves survival in septic rats: Effect on tissue inflammatory pathway and insulin signaling. Diabetes 60 (3): 784-96.
Ozsoy, R.C., Koopman, M.G., Kastelein, J.J. and Arisz, J. (2005): The acute effect of atorvastatin on proteinuria in patirnts with chronic glomerulonephritis. Clin. Nephrol. 63 (4): 245-9.
Pareek, A., Yeole, P.G., Tenpe, C.P., Chandukar, N. and Payhan, R (2009): Effect of atorvastatin and hydroxychloroquine combination on blood glucose in alloxan-induceed diabetic rats. Indian J. Pharmacol. 41 (3): 125-128.
Phoon, R.K., Kitching, A.R., Jones, L.K. and Holdsworth, S.R. (2009): Atorvastatin enhances humoral immune response but does not alter renal injury in experimental crescentic glomerulonephritis. Nephrology (Carlton) 14 (7): 650-7.
Ramadan, A. A. and Attia, E.H. R. (2003): Natural Killer molecules in cervical mucus of buffaloes during estrus cycle. 7th Sci. Egyptian Society for cattle diseases, Assuit, Egypt.
Schltz, L. A. (1987): Methods in Clinical Chemistry. The C.V. Mos. by cost Louis, 742-746.
Shi, M.Y., Xue, F.H., Teng, S.C., Jiang, L., Zhu, J., Yin, F. and Gu, H.Y. (2015): Effect of atorvastatin on serum levels of total cholesterol and high-sensitivity c-reactive protein in high risk patients with Atrial Fibrillation in Asia. Clin.Ther. 37 (8): 1740-50.
Tanaka, N., Dohmae, S.A., Iwamoto, N., Fitzgerald, M. L., and Yokoyama, S. (2012): HMG-CoA reductase inhibitors enhance phagocytosis by up regulating ATP-binding cassette transporter A7. Atherosclerosis, 217 (2): 407-414.
Vamsee, A., Joseph, A., Junaid, S., Dimple, R., George, W.Y., Naga, C.P. and Herbet, B.L. (2006): Autoimmune hepatitis triggered by statin. Journal of Clinical Gasteroenterology. 40 (8): 757-761.
Wilkinson, P.C. (1977): Technique in clinical immunology. Ed. by Thompson, R.A. publication pp. 201, USA.
Xiao, H., Chen, W., Tang, G.X., Smeekens, J.M. and Ronghu, W.U. (2015): Systemic investigation of cellular response and pleiotropic effects in atorvastatin treated liver cells by MS based proteomics. Journal of Proteome Research. 14(3): 1600-1611.
Published
Abstract Display: 152 
PDF Downloads: 168 
